Bioethics FDA Public Health 
Bill of Health
APRIL 24, 2023
Dmitry’s talk, “Evergreening: The FDA’s Role in the Creation of Balanced Rights for Pharmaceutical Improvements,” was developed into an article and published in the Iowa Law Review in 2019 titled “The More Things Change: Improvement Patents, Drug Modifications, and the FDA.”
Bill of Health
NOVEMBER 3, 2023
PROM responses can be used for purposes of clinical care, research, quality improvement, Food and Drug Administration (FDA) approval of drugs and devices, and even insurance reimbursement. Health Pol’y, Law, and Ethics 1 (2023). The post Key Considerations for Patient-Reported Outcome Measures first appeared on Bill of Health.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Health Populi
APRIL 1, 2025
In revisiting the report “six months later” in the current environment of public health and health care in the U.S. and more global political-economic currents, that Deloitte’s attention to trust, writ large, and 2030’s commitment to ESG are deeply woven into the future retail health narrative.
Bill of Health
MARCH 28, 2022
Food & Drug Administration (FDA) encouraged several states to adopt policies that prioritized race or ethnicity in the allocation of monoclonal antibody treatments and oral antivirals for the treatment of SARS-CoV-2. By James Lytle. Recent guidance from the U.S. less likely to receive the treatment than whites.
Bill of Health
SEPTEMBER 16, 2024
2025) is Assistant Professor at Brown University’s Department of Psychiatry and Human Behavior and a master’s candidate at Harvard Medical School’s Center for Bioethics. MPH 2025) is a third-year dual degree law and public health student. Zain Khalid (M.B.E Jessica Samuels (J.D./MPH
Health Populi
AUGUST 12, 2021
. “During the chaos and confusion, threat actors launched cyberattacks,” Ordr observed in the wake of the public health crisis. In this Rise of the Medical Machines, the major risks for health care organizations were that, 68% of health care deployments had more than 10 FDA recalls.
Bill of Health
NOVEMBER 18, 2022
By Aparajita Lath. The Truth Pill , authored by Dinesh Thakur and Prashant Reddy , is a monumental work that convincingly shows that drug regulation is but a myth in India. In their investigative style, the authors explain drug regulation in India through the lens of history, both Indian and global.
Expert insights. Personalized for you.
317 
Let's personalize your content